AbbVie (ABBV) Change in Acquisitions & Divestments (2012 - 2025)

AbbVie (ABBV) has reported Change in Acquisitions & Divestments for 14 consecutive years, with $34.0 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Change in Acquisitions & Divestments fell 12.82% year-over-year to $34.0 million in Q4 2025; TTM through Dec 2025 was $76.0 million, a 86.31% decrease from a year earlier, with the FY2025 full-year figure at $76.0 million, down 86.31% from the prior year.
• Change in Acquisitions & Divestments was $34.0 million for Q4 2025 at AbbVie, up from $3.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $1.4 billion in Q3 2022 and troughed at $3.0 million in Q2 2024.
• A 5-year average of $115.7 million and a median of $18.0 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments slumped 99.65% in 2023 and surged 10040.0% in 2024, its largest moves.
• Over 5 years, Change in Acquisitions & Divestments stood at $10.0 million in 2021, then soared by 600.0% to $70.0 million in 2022, then tumbled by 80.0% to $14.0 million in 2023, then soared by 178.57% to $39.0 million in 2024, then dropped by 12.82% to $34.0 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $34.0 million (Q4 2025), $3.0 million (Q3 2025), and $7.0 million (Q2 2025), per Business Quant data.